ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Exec Director, Opportunity Strategy Architect at Syneos Health - ApplyBlast

Exec Director, Opportunity Strategy Architect

Syneos Health

22 hours ago

Remote

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Exec Director, Opportunity Strategy Architect at Syneos Health leads strategic assessment and qualification of high-value clinical development opportunities before proposal and bid defense decisions. This role challenges assumptions, identifies data needs, and translates insights into client-specific strategies to win and deliver complex biopharmaceutical solutions. The position requires strong clinical trial fluency, data literacy, and the ability to influence cross-functional teams constructively.

Responsibilities

Lead structured opportunity interrogation for high-value strategic opportunities
Translate insights into opportunity diagnostics and client-specific winning strategies
Influence cross-functional teams and escalate governance issues when data is ignored

Skills

About Syneos Health

syneoshealth.com

Headquarters

Morrisville, North Carolina, United States

Company Size

10001+ employees

Founded

2017

View Profile

Syneos Health is a biopharma solutions organization and full‑service contract research organization (CRO) that integrates clinical development, regulatory and commercialization services to help life‑science companies bring therapies to market faster. It provides end‑to‑end capabilities — clinical trials across phases and therapeutic areas, real‑world evidence and data analytics, medical affairs, market access, patient engagement and commercial launch services. With a global network of scientific, clinical and commercial experts, Syneos partners with biopharma, biotech and medtech clients to de‑risk development programs and accelerate product adoption.